Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 44121 dose-ranging study for ventricular arrhythmia risk in chronic heart failure
ISRCTN14227980Phase 2Completed
- Sponsor
- Servier
- Start
- Mar 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of S44121 in arrhythmia and chronic heart failure (CHF) (4 arms), sponsored by Servier. Primary endpoint: Holter ECG efficacy measurements at week 12. Started Mar 2010; status: completed.
02
Drugs
S44121
03
Conditions
arrhythmiachronic heart failure (CHF)
Beyond the preview
Go deeper on ISRCTN14227980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14227980.